The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us


2130 Medical Laboratories
Iowa City IA 52242
(319) 335-5661; fax (319) 335-9917

Release: June 8, 1999

Individuals invited to participate in UI study on Parkinson’s disease

IOWA CITY, Iowa — University of Iowa researchers are conducting a study on how a new medication may slow the progression of Parkinson's disease.

Patients in the early stage of Parkinson's disease are invited to participate. Individuals must have had disease symptoms for less than three years and must not be taking any medication for their illness.

Participants will be randomly assigned to receive either the drug or a placebo and will be treated and followed at regular intervals for up to 26 months. There will be no charge to participate.

Persons interested in participating should contact Judy Dobson at (319) 356-8958.

Robert L. Rodnitzky, M.D., UI professor of neurology, will lead the study. The UI Hospitals and Clinics is one of 120 medical centers in the United States, Canada and Europe that will test the drug. Rhone-Poulenc Rorer of France is sponsoring the study.